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Methods & Materials: Ten-fold reductions of whole MTB (104
to 1 CFU/mL) in PS-MTMand PBS control were analyzed using Gen-
eXpert and real-time PCR on an ABI 7500. For Xpert evaluation of
clinical material, 50-150 L of smear-positive (3 + to1+ ) sputum
specimens (N=17) were transferred by ﬂocked swab into PS-MTM
and compared to equivalent amounts collected in PBS and routine
Xpert testing according to manufacturer’s recommendation.
Results: Using Xpert, MTB from PS-MTM was detected at 10
CFU/mL compared to 102 CFU/mL MTB detected from PBS controls.
Overall Xpert PCR efﬁciency from PS-MTM (63.2%) was improved
compared to PBS controls (34.9%). In Xpert, CT values from higher
MTB concentrations in PS-MTM were increased compared to con-
trol; however PS-MTM showed superior detection from low level
MTB concentrations. Xpert assay detected MTB from sputum col-
lected by ﬂocked swabs placed in PS-MTM in 17 of 17 specimens
and corresponded to routine Xpert detection using 1.0 mL of spu-
tum. NGS of multi-drug resistance genes was performed from the
volume remainder of ﬁve PS-MTM specimens. Resistance confer-
ring mutations for rifampicin were noted from two specimens in
the rpoB gene, which corresponded to Xpert rifampin-resistance
detection.
Conclusion: PS-MTMenhancesMTBdetectionwhen specimens
contain low level MTB. Sputum collection in PS-MTM provides safe
and inexpensive shipment/transport at ambient temperature to
centralized testing sites. Small sputum volume collected using a
ﬂocked swab allows the remaining sample to be safely archived,
re-tested, or evaluated for drug resistance by NGS.
http://dx.doi.org/10.1016/j.ijid.2016.02.840
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Background: Tuberculosis (TB) remains the most common
infection among HIV patients. Currently, the TB diagnosis is still
basedon the clinical presentation, radiographicﬁndings andmicro-
biological results. Considering the complexities of treating HIV/TB
co-infection,TB diagnosis requires the availability of diagnostic
tools that allow the rapid detection of Mycobacterium tuberculosis
complex (MTBC) and drug resistance in clinical samples.
Methods & Materials: In this retrospective study conducted
at the Instituto de Infectologia Emílio Ribas, São Paulo/BR, we
analized a total of 5350 clinical specimens (respiratory and extra-
pulmonary) collected from patients with signs and symptoms
suggestive of TB from January/14 toDecember/14. All sampleswere
processed by conventional diagnostic techniques, including smear
examination for acid-fast bacillus (AFB) and cultured in MGITF-
960 automated system. Blood and bone marrow were cultured in
BACTECFX. Identiﬁcation of MTBC and non-tuberculous mycobac-
teria (NTM) was performed by rapid immunochromatographic
assay. The average time needed for detection of mycobacteria was
15 days. Suscetibility testing for MTBC and PCR for NTM was per-
formed by Adolfo Lutz Institute, S. Paulo.
Results: Of the 5350 samples, 554 (10.35%) were positive by
culture for mycobacterial agents. Among the culture positive spec-
imens, 428 (77.25%) were from HIV-infected patients, and 342
(61.73%) were collected from male. From the 554 culture-positive
specimens, of which 398 (71.84%) respiratory and 156 (28.15%)
extra-pulmonary, 391 (70.57%) had a positive rapid test for MTBC
and 95 (17.14%) had a positive rapid test for NTM. From NTM,
Mycobacterium avium complex (MAC) was the most prevalent
(52.48%), followed by M. kansasii (15.78%) and M. fortuitum (5.26%).
Resistance was identiﬁed in 25/391 MTBC isolates (6.3%), and the
most frequently resistantdrugswere rifampicin (44%)and isoniazid
(32%), respectively.
Conclusion: TB is a important public health problem and
the diagnosis in HIV-infected patients is challenging. The use of
mycobacterial culture remains an important diagnostic tool. The
immediate future involves rapid molecular techniques, in partic-
ular GeneXpert which is also able to detect rifampicin resistance.
In order to improve diagnosis and detect as early as possible resis-
tance to rifampin, it was introduced earlier this year the GeneXpert
MTB/RIF in our hospital which proposes to be a strong diagnostic
tool for pulmonary TB.
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Background: Vitamin D enhances immune responses to tuber-
cle bacillus. The aim of our study was to demonstrate whether or
not use of cholecalciferol as supplement to patients with TB may
be improved clinical outcome.
Methods & Materials: Sixty patients with pulmonary tubercu-
losis were randomised to take either 450000 International Units
of cholecalciferol or placebo. Evaluation were carried out at one,
two and three months later. The ﬁrst outcome was reduction in
TB score and the secondary outcome was smear conversion and
improvement of quality of life. Analyseswere conductedusing SPSS
software (ver. 18) according to a pre-speciﬁed plan.
Results: Mean calcidiol levels for the whole study popula-
tion were within the insufﬁcient range (22.81±10.76 ng/ml).
There have been no associations between baseline calcidiol lev-
